The Parker Institute for Cancer Immunotherapy announced that Dr. Phil Greenberg, head of the Program in Immunology at the Hutch, has joined its team of more than 300 scientists from the academic, nonprofit, biotech and pharma sectors.
Volunteers roll up their sleeves and get infected to test an experimental drug
April 25, 2016
| By Mary Engel / Fred Hutch News Service
Eight healthy adults ranging in age from 20 to 37 are taking part in a new study conducted by the Seattle Malaria Clinical Trials Center, run by Fred Hutchinson Cancer Research Center and the Center for Infectious Disease Research.